Acura Pharmaceuticals (ACUR) Stock Forecast, Price & News

Acura Pharmaceuticals (OTCMKTS:ACUR) Frequently Asked Questions

Are investors shorting Acura Pharmaceuticals?

Acura Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 30,700 shares, an increase of 25.8% from the April 15th total of 24,400 shares. Based on an average daily trading volume, of 8,100 shares, the short-interest ratio is currently 3.8 days.
View Acura Pharmaceuticals' Short Interest.

When is Acura Pharmaceuticals' next earnings date?

Acura Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, June 6th 2022.
View our earnings forecast for Acura Pharmaceuticals.

How were Acura Pharmaceuticals' earnings last quarter?

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) posted its earnings results on Friday, February, 28th. The specialty pharmaceutical company reported $0.00 earnings per share (EPS) for the quarter. The specialty pharmaceutical company earned $1.32 million during the quarter.
View Acura Pharmaceuticals' earnings history.

Who are Acura Pharmaceuticals' key executives?

Acura Pharmaceuticals' management team includes the following people:

• Mr. Robert B. Jones, CEO, Pres & Director (Age 63, Pay $150k)
• Mr. Peter A. Clemens, Sr. VP, CFO & Sec. (Age 69, Pay $200k)
• Dr. Albert W. Brzeczko, VP of Pharmaceutical Sciences of Acura Pharmaceutical Technologies, Inc. (Age 65, Pay $220k)
• Mr. Robert A. Seiser CPA, Ph.D., VP, Treasurer & Corp. Controller (Age 58)

Who are some of Acura Pharmaceuticals' key competitors?

Some companies that are related to Acura Pharmaceuticals include Johnson & Johnson (JNJ), Pfizer (PFE), Eli Lilly and (LLY), AbbVie (ABBV), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics Public (HZNP), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Pacira BioSciences (PCRX), Corcept Therapeutics (CORT), Supernus Pharmaceuticals (SUPN) and Nektar Therapeutics (NKTR).
View all of ACUR's competitors.

What other stocks do shareholders of Acura Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acura Pharmaceuticals investors own include Denali Therapeutics (DNLI), Adamis Pharmaceuticals (ADMP), Ekso Bionics (EKSO), VIVUS (VVUS), Fulcrum Therapeutics (FULC), (GBSN) (GBSN), Trevena (TRVN), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA) and Advanced Micro Devices (AMD).

What is Acura Pharmaceuticals' stock symbol?

Acura Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ACUR."

How do I buy shares of Acura Pharmaceuticals?

Shares of ACUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Acura Pharmaceuticals' stock price today?

One share of ACUR stock can currently be purchased for approximately $0.53.

How much money does Acura Pharmaceuticals make?

Acura Pharmaceuticals has a market capitalization of $34.66 million and generates $3.57 million in revenue each year. The specialty pharmaceutical company earns $-1.21 million in net income (profit) each year or ($0.03) on an earnings per share basis.

How many employees does Acura Pharmaceuticals have?

Acura Pharmaceuticals employs 12 workers across the globe.

What is Acura Pharmaceuticals' official website?

The official website for Acura Pharmaceuticals is www.acurapharm.com.

How can I contact Acura Pharmaceuticals?

Acura Pharmaceuticals' mailing address is 616 N. NORTH COURT SUITE 120, PALATINE IL, 60067. The specialty pharmaceutical company can be reached via phone at (847) 705-7709, via email at [email protected], or via fax at 847-705-5399.